Su Pan
Impact in
- Cancer Research top 5%
- Cancer, Lipids, and Metabolism
- Cancer, Hypoxia, and Metabolism
- Cancer-related molecular mechanisms research
- Immunology top 10%
- Immune cells in cancer
- Immune Cell Function and Interaction
Papers in
-
- Inflammasome and immune disorders 4
-
- Ferroptosis and cancer prognosis 4
- Co-authors
- Qiang Wang (6 shared papers)Jianfei Qian (6 shared papers)Liuling Xiao (6 shared papers)Qing Yi (6 shared papers)Maojie Yang (4 shared papers)Lingqun Ye (5 shared papers)Enguang Bi (3 shared papers)Xingzhe Ma (4 shared papers)
- Journals
- British Journal of Ophthalmology (3 papers)Frontiers in Cell and Developmental Biology (2 papers)Nature Communications (2 papers)RSC Advances (2 papers)American Journal of Physiology-Lung Cellular and Molecular Physiology (2 papers)
- Partner nations
- ChinaUnited StatesNetherlands
In The Last Decade
Su Pan
46 papers receiving 1.4k citations
Su Pan's Hit Papers
Peers
Comparison fields: 5 of 106
- Cancer Research 410
- Immunology 296
- Pulmonary and Respiratory Medicine 389
- Biomaterials 149
- Oncology 275
Countries citing papers authored by Su Pan
This map shows the geographic impact of Su Pan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Su Pan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Su Pan more than expected).
Fields of papers citing papers by Su Pan
This network shows the impact of papers produced by Su Pan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Su Pan. The network helps show where Su Pan may publish in the future.
Co-authors
The 25 scholars most cited alongside Su Pan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | CD36-mediated ferroptosis dampens intratumoral CD8+ T cell effector function and impairs their antitumor ability Hit paper breakdown → | 2021 | 664 |
| 2 | 2020 | 89 | |
| 3 | 2020 | 72 | |
| 4 | 2019 | 65 | |
| 5 | 2020 | 60 | |
| 6 | 2020 | 47 | |
| 7 | 2020 | 42 | |
| 8 | 2022 | 34 | |
| 9 | 2018 | 30 | |
| 10 | 2023 | 30 | |
| 11 | 2020 | 18 | |
| 12 | 2019 | 17 | |
| 13 | 2020 | 17 | |
| 14 | 2021 | 17 | |
| 15 | 2021 | 16 | |
| 16 | 2022 | 16 | |
| 17 | 2024 | 15 | |
| 18 | 2011 | 15 | |
| 19 | 2019 | 14 | |
| 20 | 2022 | 14 |
About Su Pan
Su Pan is a scholar working on Molecular Biology, Pulmonary and Respiratory Medicine, Ophthalmology, Oncology and Immunology, having authored 48 papers that have together received 1.4k indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (5 papers), Spinal Cord Injury Research (5 papers), Nerve injury and regeneration (4 papers), Ferroptosis and cancer prognosis (4 papers), Inflammasome and immune disorders (4 papers), Electrospun Nanofibers in Biomedical Applications (3 papers), Bone Tissue Engineering Materials (3 papers) and Advanced Nanomaterials in Catalysis (3 papers). The work is most often cited by research in Cancer Research (410 citations), Immunology (296 citations), Pulmonary and Respiratory Medicine (389 citations), Biomaterials (149 citations) and Oncology (275 citations). Su Pan has collaborated with scholars based in China, United States and Netherlands. Frequent co-authors include Qiang Wang, Jianfei Qian, Liuling Xiao, Qing Yi, Maojie Yang, Lingqun Ye, Enguang Bi, Xingzhe Ma, Lintao Liu and Xiaoyu Yang. Their work appears in journals such as British Journal of Ophthalmology, Frontiers in Cell and Developmental Biology, Nature Communications, RSC Advances and American Journal of Physiology-Lung Cellular and Molecular Physiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.